Elmar A Joura

Summary

Affiliation: Medical University of Vienna
Country: Austria

Publications

  1. doi request reprint HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
    Elmar A Joura
    Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria
    Vaccine 26:6844-51. 2008
  2. ncbi request reprint Human papillomavirus in high-grade cervical lesions: Austrian data of a European multicentre study
    Lucia Rössler
    Department of Gynaecology and Obstetrics, Comprehensive Cancer Center, Medical University of Vienna, Währingergürtel 18 20, 1090, Vienna, Austria
    Wien Klin Wochenschr 125:591-9. 2013
  3. pmc Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
    Elmar A Joura
    Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    BMJ 344:e1401. 2012
  4. ncbi request reprint Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials
    Elmar A Joura
    Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria
    Lancet 369:1693-702. 2007
  5. doi request reprint Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial
    Lucia Six
    Department of Gynecology and Obstetrics, Women s Health Clinic, Medical University of Vienna, Vienna, Austria
    Wien Klin Wochenschr 120:666-71. 2008
  6. doi request reprint Human papillomavirus infections and vulvar disease development
    Suzanne M Garland
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Medical University of Vienna, Allgemeines Krankenhaus der Stadt Wien, Vienna, Austria
    Cancer Epidemiol Biomarkers Prev 18:1777-84. 2009
  7. ncbi request reprint Groin metastasis after extensive microinvasive vulvar cancer. A case report
    Christiane Schausberger
    Department of Gynecology and Pathology, Medical University of Vienna, Allgemeines Krankenhaus, Vienna, Austria
    J Reprod Med 52:78-80. 2007
  8. doi request reprint Human papilloma virus infection prior to coitarche
    Daniela Doerfler
    Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria
    Am J Obstet Gynecol 200:487.e1-5. 2009
  9. ncbi request reprint Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy
    Andreas Nather
    Department of Gynecology and Obstetrics, Vienna University Medical School, A 1090 Vienna, Wahringer Gurtel 18 20, Austria
    Anticancer Res 23:2991-4. 2003
  10. ncbi request reprint Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia
    Elmar A Joura
    Department of Gynecology and Obstetrics, University of Vienna, Vienna, Austria
    Curr Opin Obstet Gynecol 14:39-43. 2002

Detail Information

Publications11

  1. doi request reprint HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine
    Elmar A Joura
    Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria
    Vaccine 26:6844-51. 2008
    ..4%; 95% CI: 90.5-100.0) despite high attack rates in the placebo group. These results suggest vaccine-induced protection via immune memory, or lower than detectable HPV 18 antibody titers...
  2. ncbi request reprint Human papillomavirus in high-grade cervical lesions: Austrian data of a European multicentre study
    Lucia Rössler
    Department of Gynaecology and Obstetrics, Comprehensive Cancer Center, Medical University of Vienna, Währingergürtel 18 20, 1090, Vienna, Austria
    Wien Klin Wochenschr 125:591-9. 2013
    ..This study was undertaken to assess human papillomavirus (HPV) type distribution in high-grade cervical lesions...
  3. pmc Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
    Elmar A Joura
    Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    BMJ 344:e1401. 2012
    ....
  4. ncbi request reprint Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials
    Elmar A Joura
    Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria
    Lancet 369:1693-702. 2007
    ..Our aim was to do a combined analysis of three randomised clinical trials to assess the effect of a prophylactic quadrivalent HPV vaccine on the incidence of these diseases...
  5. doi request reprint Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial
    Lucia Six
    Department of Gynecology and Obstetrics, Women s Health Clinic, Medical University of Vienna, Vienna, Austria
    Wien Klin Wochenschr 120:666-71. 2008
    ..HPV types 6 and 11 are the causative agent of > 90% of genital warts. The aim of this study was to assess the baseline prevalence of infection with HPV 6, 11, 16 and 18 in young Austrian women...
  6. doi request reprint Human papillomavirus infections and vulvar disease development
    Suzanne M Garland
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Medical University of Vienna, Allgemeines Krankenhaus der Stadt Wien, Vienna, Austria
    Cancer Epidemiol Biomarkers Prev 18:1777-84. 2009
    ....
  7. ncbi request reprint Groin metastasis after extensive microinvasive vulvar cancer. A case report
    Christiane Schausberger
    Department of Gynecology and Pathology, Medical University of Vienna, Allgemeines Krankenhaus, Vienna, Austria
    J Reprod Med 52:78-80. 2007
    ..An increasing incidence of vulvar intraepithelial neoplasia and microinvasive vulvar cancer is being observed in younger patients. The treatment of choice is wide local excision...
  8. doi request reprint Human papilloma virus infection prior to coitarche
    Daniela Doerfler
    Department of Gynecology and Obstetrics, Medical University of Vienna, Vienna, Austria
    Am J Obstet Gynecol 200:487.e1-5. 2009
    ..The aim of our study was to determine the prevalence and the natural course of anogenital human papilloma virus (HPV) infections in girls prior to coitarche attending an outpatient gynecological unit...
  9. ncbi request reprint Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy
    Andreas Nather
    Department of Gynecology and Obstetrics, Vienna University Medical School, A 1090 Vienna, Wahringer Gurtel 18 20, Austria
    Anticancer Res 23:2991-4. 2003
    ..To investigate the incidence and the prognostic value of platelet count and serum haemoglobin (Hb) in patients with recurrent ovarian cancer prior to second-line chemotherapy...
  10. ncbi request reprint Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia
    Elmar A Joura
    Department of Gynecology and Obstetrics, University of Vienna, Vienna, Austria
    Curr Opin Obstet Gynecol 14:39-43. 2002
    ..Preliminary results of topical antiviral agents and photodynamic therapy are available, but remain to be confirmed by prospective, placebo-controlled studies...
  11. ncbi request reprint Serum levels of squamous cell carcinoma antigen as a predictor of inguinofemoral lymph node metastasis in patients with vulvar cancer
    Andreas Nather
    Department of Gynecology and Obstetrics, University of Vienna General Hospital, Wahringer Gurtel 18 20, A 1090 Vienna, Austria
    J Reprod Med 47:718-20. 2002
    ..To evaluate the predictive value of preoperatively determined squamous cell carcinoma antigen (SCC-Ag) serum levels for the risk of inguinofemoral lymph node metastasis...